Peripheral neuropathy in severe COVID‐19 resolved with therapeutic plasma exchange
Fahad Faqihi, Abdulrahman Alharthy, Ziad A. Memish, Demetrios J. Kutsogiannis, Peter G. Brindley, Dimitrios Karakitsos
Abstract
Peripheral neuropathies including Guillain-Barré syndrome may be linked to life-threatening COVID-19. Plasma exchange is a safe rescue therapy in severe COVID-19 with associated neurological manifestations and thromboinflammation.
Topics & Concepts
MedicineTherapeutic plasma exchangeCoronavirus disease 2019 (COVID-19)Peripheral neuropathy2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicineInternal medicineVirologyDiseaseDiabetes mellitusEndocrinologyOutbreakInfectious disease (medical specialty)Peripheral Neuropathies and DisordersLong-Term Effects of COVID-19Pain Mechanisms and Treatments